Dark versionDefault version
Kim Lang

Kim Lang

Instructional Design Leader | Driving Learning Innovation

AI 90-Day Implementation Roadmap

A lightbulb representing AI that reads 90-day Implementation Roadmap

The Problem

Organizations and individuals want to adopt AI but don’t know where to start, what sequence to follow, or how to measure success—leading to scattered adoption, wasted investment, and failure to achieve ROI.

Description

This structured 90-day plan guides systematic AI integration through three phases: Foundation (Days 1-30: assessment, first tool, first project, 20-30% savings), Integration (Days 31-60: workflow integration, second tool, team training, 30-40% savings), and Optimization (Days 61-90: process refinement, organizational scaling, 40-50% sustained savings). Each week includes specific action items with checkboxes, success criteria, ROI tracking framework, and common challenge solutions.

ROI Framework for AI Integration

A lightbulb representing AI that reads ROI Framework

The Problem

Instructional designers and leaders struggle to quantify the value of AI investments, making it difficult to secure budget approval, justify tool subscriptions, and demonstrate the business impact of AI adoption.

Description

This comprehensive framework provides the methodology, formulas, and real-world examples needed to calculate, track, and communicate AI ROI. It includes research-backed time savings data by task type (70-90% for high-impact activities), detailed ROI calculation methodology with step-by-step examples, three real-world scenarios showing 900-1,000% first-year ROI, monthly and quarterly tracking templates, and best practices for maximizing returns. The document demonstrates that typical break-even occurs within 2-5 weeks with sustained productivity gains of 35-50%.

Needs Analysis Introduction

A magnifying glass on top of a report with the words Needs Analysis Introduction

The Problem

Following Omnicell’s acquisition of InPharmics in April 2017, the organization needed to rapidly commercialize the DSCSA Management Module to capitalize on an urgent market opportunity. With a critical November 2017 federal regulatory deadline approaching—requiring manufacturers to provide electronic transaction records and implement 2D barcodes—hospital pharmacies across the country desperately needed compliance solutions. However, without comprehensive training materials, Omnicell risked losing market share to competitors and failing to generate expected revenue from the newly acquired 150-hospital customer base. Leadership required a strategic assessment to determine the optimal training approach, identify implementation risks, and establish a clear development roadmap that would enable successful product launch while meeting the compressed regulatory timeline.

Description

I led a comprehensive needs analysis to evaluate training requirements for Omnicell’s newly acquired DSCSA Management Module, a critical compliance tool for hospital pharmacies navigating complex federal drug supply chain regulations. This strategic assessment directly supported revenue generation by enabling the commercialization of the InPharmics acquisition.
The analysis addressed multiple stakeholder needs across product management, marketing, and customer success teams. I conducted stakeholder interviews with subject matter experts, evaluated existing training resources, and assessed the technical learning requirements for Directors of Pharmacy (DOPs) who would be primary users of the module.

Key deliverables included:

Strategic Recommendations: Developed a multi-modal training strategy featuring Adobe Captivate simulations and online modules, optimizing for both customer accessibility and scalability across 150+ hospitals.
Risk Assessment: Identified critical project risks including staffing constraints, release timeline pressures, and technical dependencies. Proactively flagged the impact of instructional designer vacancy and interface branding updates on project delivery.

Resource Planning: Established development requirements, timelines (4-week delivery with 100-hour estimate), and cross-functional dependencies to ensure successful execution.

Stakeholder Alignment: Documented open questions regarding long-term customer support, workflow integration with InPharma services, and module access protocols to facilitate executive decision-making.

This needs analysis provided leadership with the data-driven insights necessary to make informed investment decisions and successfully launch DSCSA training ahead of the November 2017 regulatory deadline. The resulting training modules supported customer compliance and contributed to revenue generation from the InPharmics product line.

Development of the Subscription Training Program

Hands holding globe with the words Subscription Training Program

The Problem

Omnicell faced a competitive disadvantage in the healthcare technology training market. Customers—particularly hospital directors of pharmacy and pharmacy techs—required ongoing, flexible access to training as new employees joined, software updates rolled out, and regulatory requirements evolved. However, the traditional pay-per-course model created budget barriers that limited training participation and left system administrators and super users inadequately prepared to support their facilities. Additionally, the sales team lacked differentiated training offerings to compete effectively against rivals. The organization needed an innovative training business model that would generate predictable recurring revenue, provide unlimited value to customers, and give sales a competitive edge in contract negotiations.

Description

I designed and launched Omnicell’s first subscription-based training program, creating a new revenue stream while solving critical customer pain points around training accessibility and cost predictability. This program represented a fundamental shift in the company’s training business model and became a key competitive differentiator that sales teams leveraged to win contracts.

Program Design & Strategy: The subscription model provided unlimited training access tailored to different user roles within healthcare facilities. Pharmacists and system administrators received unlimited instructor-led training (ILT) and virtual instructor-led training (VILT) sessions across multiple product lines including Central Pharmacy Manager, Controlled Substance Manager, and Point of Use systems. Nursing staff gained unlimited access to eLearning modules through the organization’s partnership with HealthStream, ensuring frontline clinical staff could access just-in-time training.

Cross-Functional Leadership: I collaborated with Operations and Sales leadership to secure approval for program development, build internal buy-in, and establish pricing models that balanced customer value with revenue goals. This required presenting business cases, addressing operational concerns, and aligning stakeholders across multiple departments on the strategic benefits of recurring revenue.

Market Impact: The subscription model quickly became the preferred purchasing option, with the majority of facilities choosing subscriptions over traditional à la carte training after the program launched. Sales teams successfully positioned the unlimited training access as a compelling value proposition that differentiated Omnicell from competitors, directly contributing to contract wins and customer retention.

Product Features:

  • Flexible delivery modalities (VILT and eLearning) optimized for different learner needs
  • Comprehensive course catalog covering pre-installation basics through advanced system optimization
  • Scalable model supporting multiple users per facility without additional per-seat costs
  • Registration system enabling any system administrator or super user to access training with facility subscription number

This innovative program demonstrated my ability to identify market opportunities, develop new business models, secure cross-functional support, and create scalable solutions that drive both customer satisfaction and organizational revenue growth.